Highest development stage: Phase 2

Development status: Inactive

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: Against Klebsiella pneumoniae, Proteus mirabalis and Pseudomonas aeruginosa, ME1228 is more potent than cefpirome, ceftazidime and flomoxef.